"Development of small molecule drugs and radiopharmaceuticals"

The field of small molecules focuses on developing pharmaceuticals through organic chemical synthesis. Our goal is to develop drugs targeting various biomarkers for imaging, treatment, or both. We primarily focus on biomarkers such as fibroblast activation protein (FAP), prostate specific membrane antigen (PSMA), and translocator protein (TSPO), with significant ongoing research in these areas. In addition, various other studies are being conducted. The efficacy of the synthesized compounds is verified through in vitro and in vivo experiments. The ultimate objective is to translate innovative research into clinical trial applications.